Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Disability and progression in Afro-descendant patients with multiple sclerosis.
Brain atrophy measurements should be used to guide therapy monitoring in MS - Commentary.
Contraceptive use among women with multiple sclerosis: a systematic review.
Reducing the economic burden in management of Guillain-Barre syndrome using modified plasmapheresis.
Assessing response to interferon-β in a multicenter dataset of patients with MS.
Germinoma Mimicking Tumefactive Demyelinating Disease in Pediatric Patients.
[Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in the province of Alicante].
Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy.
Righting Reflex Predicts Long-Term Histological and Behavioral Outcomes in a Closed Head Model of Traumatic Brain Injury.
Tamoxifen: an FDA approved drug with neuroprotective effects for spinal cord injury recovery.
Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial.
Retinal imaging and axonal degeneration in later onset multiple sclerosis.
Multi-Parametric Non-Negative Matrix Factorization for Longitudinal Variations Detection in White Matter Fiber-Bundles.
Therapy of Vestibular Paroxysmia, Superior Oblique Myokymia, and Ocular Neuromyotonia.
Anti-CD20 monoclonal antibodies in multiple sclerosis.
The choroid plexus in health and in disease: Dialogues into and out of the brain.
A Semiautomatic Method for Multiple Sclerosis Lesion Segmentation on Dual-Echo MR Imaging: Application in a Multicenter Context.
The role of sleep on cognition and functional connectivity in patients with multiple sclerosis.
'Non-criteria' neurologic manifestations of antiphospholipid syndrome: A hidden kingdom to be discovered.
Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy.
Extensive and severe CNS demyelination associated with golimumab therapy.
[Cerebrospinal fluid diagnostics in multiple sclerosis].
Sex differences and subclinical retinal injury in pediatric-onset MS.
Pediatric Acute Longitudinal Extensive Transverse Myelitis Secondary to Neuroborreliosis.
Decrease in rate of multiple sclerosis-related hospitalizations in Portugal.
Pages
« first
‹ previous
…
778
779
780
781
782
783
784
785
786
…
next ›
last »